AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Wyeth wins one, loses one.(Digest)(Brief Article)

Chain Drug Review

| September 27, 2004 | COPYRIGHT 2004 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

In the case of two women who filed a lawsuit against the company alleging heart valve damage as a result of taking a company diet drug, a jury has found in favor of one plaintiff in one part of the case but in favor of Wyeth in the second part. The jury originally awarded the winning plaintiff $50,000, but she and the company have since agreed to settle for an undisclosed ...

Related articles from newspapers, magazines, journals, and more
Wyeth wins another diet drug trial.(Brief article)
Newspaper article from: Pharma Marketletter March 27, 2006 700+ words
US drug major Wyeth has announced that the jury in the cases of Joyce Townley versus Wyeth and Pamela Williams vs Wyeth in the Philadelphia Court of Common Pleas, which concerned claims of damages caused by the firm's long-withdrawn diet drugs, found in favor of the company in both cases. "We are
Wyeth wins hormone therapy trial.(Digest)(Brief article)
Magazine article from: Chain Drug Review March 19, 2007 700+ words
A federal court sitting in Arkansas has ruled in favor of Wyeth in a case involving Premarin and Prempro. The plaintiff had alleged that she had developed breast cancer from use of the hormone therapy treatment.
Wyeth wins PA diet drug trial.(Brief Article)
Newspaper article from: Pharma Marketletter March 7, 2005 700+ words
US drug major Wyeth says that the jury in the cases of Melinda Hoyt versus Wyeth and DaLene Marlowe vs Wyeth in the Court of Common Pleas in Philadelphia has found in favor of Wyeth. The verdict came at the close of the first phase, the damages stage, of this bifurcated trial. This completes the
Wyeth wins multiple Philadelpha diet drug cases.(Brief Article)
Newspaper article from: Pharma Marketletter August 23, 2004 700+ words
Wyeth has announced that the jury deliberating over four combined fen-phen diet drug cases in the Court of Common Pleas of the First Judicial District of Pennsylvania has returned a verdict in favor of the company (Marketletters passim). The four cases were brought by Florence Ford, Lynette
Wyeth wins Philadelphia HRT trial.(hormone replacement therapy)(Brief article)
Newspaper article from: Pharma Marketletter May 21, 2007 700+ words
US drug major Wyeth says that the jury in the case of Merle and Steven Simon versus Wyeth, in the Philadelphia Court of Common Pleas, which concerned a claim of increased risk of cancer due to use of the firm's hormone replacement therapy drugs Premarin (conjugated estrogens) and Prempro
Wyeth wins Los Angeles diet drug trial.(Wyeth Pharmaceuticals)(Brief Article)
Newspaper article from: Pharma Marketletter November 14, 2005 700+ words
A jury in the cases of Paula Falzon versus Wyeth, Melinda Galgoul vs Wyeth, Paula Kraskian vs Wyeth and Vicki Felton-Mallut vs Wyeth in the Los Angeles Superior Court, USA, concerning alleged damage caused by the diet drug Pondamin (fenfluramine), has found in favor of Wyeth in all four cases. "We
Wyeth wins one of two PA diet drug cases.(Philadelphia)(Brief Article)
Newspaper article from: Pharma Marketletter January 3, 2005 700+ words
US drug major Wyeth has said that the jury deliberating in the cases of Judi Ellis versus Wyeth and Brigitt Redman vs Wyeth in the Court of Common Pleas in Philadelphia, found in favor of the company in the Redman case and for the plaintiff in that for Ms Ellis, awarding her $250,000 in
Wyeth wins further diet drug cases.(Wyeth Pharmaceuticals Proprietary Ltd.'s...
Newspaper article from: Pharma Marketletter April 18, 2005 700+ words
The jury in the cases of Camille Olsen versus Wyeth and Isabel Vega vs Wyeth in the USA's Philadelphia Court of Common Pleas has found in favor of the US drugmaker in the second, liability phase of this bifurcated (two-phase) trial relating to the company's fenfluramine-based diet drugs. Although
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA